Search
New Alzheimer’s Trial to Combine Anti-Amyloid and Anti-Tau Therapies to Arrest Disease Progression
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two drugs that target disease-driving proteins to see whether their effects can be amplified.Why Has Progress in the Treatment of Alzheimer’s Disease Taken 30 Years?
UCSF expert examines the past and future of clinical trials for Alzheimer’s Disease.Headache Center Inpatient Referral Guide
As the only program with an Inpatient Headache Treatment Unit in Northern California, UCSF’s Headache Center helps improve the quality of life for individuals suffering from debilitating headaches.